To enhance the role targeting, design to link NGR sequence with tumstatin active peptides-T(7)'s C-terminal, the derivant called T(7)-NGR. The cloning vector pMD-T(7) and pMD-T(7) N were constructed by PCR and gene synthesis methods, respectively, identified by digestion and DNA sequencing. After the digested plasmids were isolated by the low melting point agarose electrophoresis, the target-fragment was cut off and mixed with the recovery of the digested vector pET28a. Expression vector pET-T(7) and pET-T(7) N were constructed in low melting point agarose, identified by digestion and DNA sequencing, transformed into competent Escherichia coli BL21 (DE3), induced by IPTG. Identification result shows that pET-T(7) and pET-T(7) N were correct. Tricine-SDS-PAGE results showed that IPTG concentration of 1 mM, after the induction of 25 degrees C, 8 h, T(7) peptides and T(7)-NGR peptides have achieved the optimum conditions of expression. In conclusion, the expression vectors of the two peptides has been successfully constructed, and got product, no coverage at home and abroad, laid the foundation for further activity experiments.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10238-008-0029-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization of Ocular Morphology in Col4a3-/- Mice as a Murine Model for Alport Syndrome.
Transl Vis Sci Technol
July 2024
Department of Ophthalmology, Peking University First Hospital, Xicheng District, Beijing, China.
Article Synopsis
- The study aimed to explore the eye-related characteristics and potential disease mechanisms in Col4a3-/- mice, which serve as a model for Alport syndrome (AS).
- Researchers examined collagen IV expression and performed various tests to analyze the structural integrity of different eye tissues, comparing Col4a3-/- mice with wild-type (WT) mice.
- Findings revealed significant ocular changes in Col4a3-/- mice, including thinner lens capsules, altered corneal structures, and enhanced Müller cell activation, suggesting parallels to AS in human patients and potential avenues for treatment research.
Tauroursodeoxycholic acid ameliorates renal injury induced by COL4A3 mutation.
Kidney Int
September 2024
Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Institute of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:
COL4A3/A4/A5 mutations have been identified as critical causes of Alport syndrome and other genetic chronic kidney diseases. However, the underlying pathogenesis remains unclear, and specific treatments are lacking. Here, we constructed a transgenic Alport syndrome mouse model by generating a mutation (Col4a3 p.
View Article and Find Full Text PDFT7 peptide-mediated co-delivery platform overcoming multidrug-resistant breast cancer: In vitro and in vivo evaluation.
Eur J Pharm Biopharm
July 2024
School of Chemical Engineering, Sichuan University, Chengdu 610065, China. Electronic address:
P-glycoprotein (P-gp) overexpressed mutidrug resistance (MDR) is currently a key factor limiting the effectiveness of breast cancer chemotherapy. Systemic administration based on P-gp-associated mechanism leads to severe toxic side effects. Here, we designed a T7 peptide-modified mixed liposome (T7-MLP@DTX/SchB) that, by active targeting co-delivering chemotherapeutic agents and P-gp inhibitors, harnessed synergistic effects to improve the treatment of MDR breast cancer.
View Article and Find Full Text PDFCirculating Podocalyxin, Tumstatin/Col-IVα3 and Chitinase 1: New Culprits in Vitiligo Occurrence.
Dermatol Pract Concept
January 2024
Department of Dermatology, Gozde Academy Hospitals, Malatya, Turkey.
Introduction: The roles of anti-adhesive podocalyxin (PODXL), anti-angiogenetic tumstatin/ Col-IVα3 and neuro-inflammation and innate immunity modulator Chitinase 1 (CHIT-1) in the etiology of vitiligo have not been studied yet.
Objectives: This study was planned to detect changes in serum PODXL, tumstatin/Col-IVα3 and CHIT1 levels in vitiligo patients.
Methods: This case-controlled study was performed on a total of 50 patients, 25 with vitiligo and 25 healthy controls.
Identification of unique α4 chain structure and conserved antiangiogenic activity of α3NC1 type IV collagen in zebrafish.
Dev Dyn
July 2023
Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Background: Type IV collagen is an abundant component of basement membranes in all multicellular species and is essential for the extracellular scaffold supporting tissue architecture and function. Lower organisms typically have two type IV collagen genes, encoding α1 and α2 chains, in contrast with the six genes in humans, encoding α1-α6 chains. The α chains assemble into trimeric protomers, the building blocks of the type IV collagen network.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!